Integrated Biopharma, Inc. Reports Earnings Results for the Third Quarter Ended March 31, 2021
May 13, 2021 at 02:02 pm
Share
Integrated BioPharma, Inc. announced earnings results for the third quarter ended March 31, 2021. For the third quarter, the company announced sales was USD 17.072 million compared to USD 13.631 million a year ago. Operating income was USD 1.719 million compared to USD 960,000 a year ago. Net income was USD 1.241 million compared to USD 936,000 a year ago. Basic earnings per share from continuing operations was USD 0.04 compared to USD 0.03 a year ago. For the nine months, sales was USD 46.501 million compared to USD 39.234 million a year ago. Operating income was USD 4.472 million compared to USD 2.641 million a year ago. Net income was USD 3.506 million compared to USD 2.207 million a year ago. Basic earnings per share from continuing operations was USD 0.12 compared to USD 0.07 a year ago. Diluted earnings per share from continuing operations was USD 0.11 compared to USD 0.07 a year ago.
Integrated Biopharma Inc. is engaged primarily in manufacturing, distributing, marketing and sales of vitamins, nutritional supplements, and herbal products. The Companyâs business segments include Contract Manufacturing operated by Manhattan Drug Company, Inc. (MDC), which manufactures vitamins and nutritional supplements for sale to distributors, multilevel marketers and specialized health-care providers; and Other Nutraceutical Businesses, which includes the operations of AgroLabs, Inc. (AgroLabs), The Vitamin Factory (the Vitamin Factory), IHT Health Products, Inc. (IHT), MDC Warehousing and Distribution, Inc., and Chem International, Inc. AgroLabs distributes healthful nutritional products for sale through mass market, grocery and drug and vitamin retailers under the brands: Peaceful Sleep, and Wheatgrass and other products. IHT is a distributor of fine natural botanicals, including multi-minerals produced under a license agreement. Chem is a distributor of raw materials.